Cargando…

Glutathione Deficiency in Cardiac Patients Is Related to the Functional Status and Structural Cardiac Abnormalities

BACKGROUND: The tripeptide glutathione (L-gamma-glutamyl-cysteinyl-glycine) is essential to cell survival, and deficiency in cardiac and systemic glutathione relates to heart failure progression and cardiac remodelling in animal models. Accordingly, we investigated cardiac and blood glutathione leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damy, Thibaud, Kirsch, Matthias, Khouzami, Lara, Caramelle, Philippe, Le Corvoisier, Philippe, Roudot-Thoraval, Françoise, Dubois-Randé, Jean-Luc, Hittinger, Luc, Pavoine, Catherine, Pecker, Françoise
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655715/ https://www.ncbi.nlm.nih.gov/pubmed/19319187 http://dx.doi.org/10.1371/journal.pone.0004871

Ejemplares similares

Posterior longitudinal strain by speckle tracking echocardiography, marker of cardiac amyloidosis?
por: Ternacle, Julien, et al.
Publicado: (2015)

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
por: Galat, Arnault, et al.
Publicado: (2015)

Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study
por: Bodez, Diane, et al.
Publicado: (2016)

Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism
por: Damy, Thibaud, et al.
Publicado: (2011)

Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure
por: Berthelot, Emmanuelle, et al.
Publicado: (2023)

Prevalence and determinants of iron deficiency in cardiac amyloidosis
por: Jobbé‐Duval, Antoine, et al.
Publicado: (2022)

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020)

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2023)

Long-term complications of splenectomy in adult immune thrombocytopenia
por: Thai, Lan-Huong, et al.
Publicado: (2016)

Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
por: Aouate, David, et al.
Publicado: (2020)

Microbial Dysbiosis in Colorectal Cancer (CRC) Patients
por: Sobhani, Iradj, et al.
Publicado: (2011)

Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS).
por: Pol, Stanislas, et al.
Publicado: (2021)

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
por: Kharoubi, Mounira, et al.
Publicado: (2021)

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study
por: Thibault, Vincent, et al.
Publicado: (2013)

Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014
por: Sanna, Alice, et al.
Publicado: (2017)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement
por: Galat, Arnault, et al.
Publicado: (2019)

Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature
por: Adam, Robert Daniel, et al.
Publicado: (2021)

Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs
por: Chevaliez, Stéphane, et al.
Publicado: (2020)

Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study
por: Chevaliez, Stéphane, et al.
Publicado: (2022)

Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial
por: Le Corvoisier, Philippe, et al.
Publicado: (2018)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
por: Guendouz, Soulef, et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications
por: Mohty, Dania, et al.
Publicado: (2023)

Comparison and identification of early clinical, biological and echocardiographic prognostic markers in cardiac amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Left ventricular and atrial function in systemic light chains amyloidosis: an echocardiography and cardiac magnetic resonance comparison
por: Mohty, Dania, et al.
Publicado: (2015)

Cardiac Surgery in Advanced Heart Failure
por: Hullin, Roger, et al.
Publicado: (2022)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

RNA Structural Requirements for Nucleocapsid Protein-Mediated Extended Dimer Formation
por: Chaminade, Françoise, et al.
Publicado: (2022)

Good performance in the management of acute heart failure in cardiogeriatric departments: the ICREX-94 experience
por: Berthelot, Emmanuelle, et al.
Publicado: (2021)

DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis
por: Akinboboye, Olakunle, et al.
Publicado: (2015)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
por: Fischer, Kilian, et al.
Publicado: (2021)

Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Cardiac calcified amorphous tumor: A systematic review of the literature
por: de Hemptinne, Quentin, et al.
Publicado: (2015)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
por: Ridouani, Fourat, et al.
Publicado: (2018)

Calcium-Binding Properties and ATPase Activities of Rat Liver Plasma Membranes
por: Chambaut, Anne-Marie, et al.
Publicado: (1974)

Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages
por: Besse, Sophie, et al.
Publicado: (2022)

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
por: Oghina, Silvia, et al.
Publicado: (2021)

Cardiac Acetylation in Metabolic Diseases
por: Dubois-Deruy, Emilie, et al.
Publicado: (2022)

Ankylosing Spondylitis and Cardiac Abnormalities
por: Yang, Dong Heon
Publicado: (2012)

Ictal Cardiac Ryhthym Abnormalities
por: Ali, Rushna
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dva22ml9glu3smb08llg5mhmip